Zurich-based Blue Horizon Ventures closed its inaugural flagship fund, Blue Horizon Ventures I, at €183 million ($222 million), exceeding its initial target size.
The fund’s focus is on supporting a positive impact on the environment and human health with an investment focus on alternative proteins, synthetic biology, cultivated food, smart packaging and food waste.
“The global capital, accelerated by the global COVID-19 pandemic is moving towards impact at great speed,” said Michael Kleindl, founder and managing partner of Blue Horizon Ventures. “This allows more and more entrepreneurs to start their ventures in . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.
